424 related articles for article (PubMed ID: 28116631)
1. Translational initiatives in thrombolytic therapy.
Klegerman ME
Front Med; 2017 Mar; 11(1):1-19. PubMed ID: 28116631
[TBL] [Abstract][Full Text] [Related]
2. Liposomal nanocarriers for plasminogen activators.
Koudelka S; Mikulik R; Mašek J; Raška M; Turánek Knotigová P; Miller AD; Turánek J
J Control Release; 2016 Apr; 227():45-57. PubMed ID: 26876783
[TBL] [Abstract][Full Text] [Related]
3. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
4. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
5. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Maksimenko AV; Tischenko EG
J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713
[TBL] [Abstract][Full Text] [Related]
6. The evolution of recombinant thrombolytics: Current status and future directions.
Adivitiya ; Khasa YP
Bioengineered; 2017 Jul; 8(4):331-358. PubMed ID: 27696935
[TBL] [Abstract][Full Text] [Related]
7. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
Topol EJ
Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
[No Abstract] [Full Text] [Related]
8. [Fibrinolytic agents--who benefits when?].
Weichert W; Seifried E
Ther Umsch; 1995 Oct; 52(10):652-60. PubMed ID: 7482376
[TBL] [Abstract][Full Text] [Related]
9. Novel and emerging therapies: thrombus-targeted fibrinolysis.
Lippi G; Mattiuzzi C; Favaloro EJ
Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
[TBL] [Abstract][Full Text] [Related]
10. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic therapy: clinical applications.
Baker WF
Hematol Oncol Clin North Am; 2003 Feb; 17(1):283-311. PubMed ID: 12627672
[TBL] [Abstract][Full Text] [Related]
12. [Staphylokinase--a specific plasminogen activator].
Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
[TBL] [Abstract][Full Text] [Related]
13. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
Motomiya T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
[No Abstract] [Full Text] [Related]
14. Thrombolytic therapy for acute myocardial infarction--round 2.
Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
[No Abstract] [Full Text] [Related]
15. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
16. Fibrin-specific thrombolytic agents.
Collen D
Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
[TBL] [Abstract][Full Text] [Related]
17. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
Gurewich V
Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
[No Abstract] [Full Text] [Related]
18. Mechanism of action and thrombolytic potential of staphylokinase.
Lijnen HR
Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
[TBL] [Abstract][Full Text] [Related]
19. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
[TBL] [Abstract][Full Text] [Related]
20. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
Bell WR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
